Ontology highlight
ABSTRACT: Background
Evidence supports several countries introducing legislation to allow cannabis-based medicine as an adjunctive treatment for the symptomatic relief of chronic pain, chemotherapy-induced nausea, spasticity in multiple sclerosis (MS), epileptic seizures, depression, and anxiety. However, clinical trial participants do not represent the entire spectrum of disease and health status seen in patients currently accessing medicinal cannabis in practice.Objective
This study aims to collect real-world data to evaluate health-related quality of life in patients prescribed medicinal cannabis oil and describe any differences over time, from before starting therapy to after 3 and 12 months of therapy.Methods
Adult patients newly prescribed medicinal cannabis oil by auth
SUBMITTER: Tait MA
PROVIDER: S-EPMC8663597 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature